CSPC PHARMA (01093): The trustee purchased a total of 2.8 million shares under the stock reward plan.
YaoPharma Group (01093) announced that on June 16, 2026, the trustee purchased a total of 2.8 million shares of the company in the market according to the terms and conditions of the 2026 stock incentive plan, and held the shares in trust for the benefit of selected participants.
CSPC PHARMA (01093) announced that on June 16, 2026, the trustee purchased a total of 2.8 million shares of the company in the market according to the terms and conditions of the 2026 stock incentive plan, and held these shares in trust for the benefit of the selected participants.
Related Articles
BAYZED HEALTH (02609): Lv Chao appointed as executive director.
Goldwind Science & Technology (02208) will distribute a final dividend of HK$0.23005 per share on August 7th.
Hebei Gongda Keya Technology Group's major shareholder, China System, plans to transfer 10.54% of the company's shares through public solicitation.
BAYZED HEALTH (02609): Lv Chao appointed as executive director.
Goldwind Science & Technology (02208) will distribute a final dividend of HK$0.23005 per share on August 7th.
Hebei Gongda Keya Technology Group's major shareholder, China System, plans to transfer 10.54% of the company's shares through public solicitation.
RECOMMEND
